The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Mechanisms of Disease
PreviousPrevious
Volume 357:1121-1135 September 13, 2007 Number 11
NextNext

Myocardial Reperfusion Injury
Derek M. Yellon, D.Sc., and Derek J. Hausenloy, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Coronary heart disease is the leading cause of death worldwide, and 3.8 million men and 3.4 million women die of the disease each year. After an acute myocardial infarction, early and successful myocardial reperfusion with the use of thrombolytic therapy or primary percutaneous coronary intervention (PCI) is the most effective strategy for reducing the size of a myocardial infarct and improving the clinical outcome. The process of restoring blood flow to the ischemic myocardium, however, can induce injury. This phenomenon, termed myocardial reperfusion injury, can paradoxically reduce the beneficial effects of myocardial reperfusion.

The potentially detrimental aspect of myocardial reperfusion . . . [Full Text of this Article]

Myocardial Reperfusion Injury and Cell Death

Potential Mediators of Lethal Reperfusion Injury

Oxygen Paradox

Calcium Paradox

pH Paradox

Inflammation

Metabolic Modulation

Magnesium Therapy

Therapeutic Hypothermia

Mitochondrial PTP

Targeting Lethal Reperfusion Injury

New Strategies for Preventing Lethal Reperfusion Injury

Ischemic Postconditioning

Targeting the RISK Pathway

Targeting the Mitochondrial PTP

Wavefront of Reperfusion Injury

Conclusions


Source Information

From the Hatter Cardiovascular Institute, University College London Hospital and Medical School, London.

Address reprint requests to Dr. Yellon at the Hatter Cardiovascular Institute, University College London Hospital and Medical School, 67 Chenies Mews, London WC1E 6HX, United Kingdom, or at hatter-institute@ucl.ac.uk.


Related Letters:

Myocardial Reperfusion Injury
Ramaraj R., Forman M. B., Jackson E. K., Lowenstein C. J., Ibanez B., Cimmino G., Badimon J. J., Korantzopoulos P. G., Goudevenos J. A., Yellon D. M., Hausenloy D. J.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:2408-2410, Dec 6, 2007. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.